Hui-Jing Yu, PhD

Critic
DISC Type : C

Director, Clinical Science at Alnylam Pharmaceuticals

Cambridge, Massachusetts, United States

Overview

Dr. Hui-Jing Yu is a strategic clinical development leader at Alnylam Pharmaceuticals, focusing on CNS therapeutics. With a Ph. D. from Stony Brook University and over 15 years in neuroscience, her expertise lies in advancing therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s, leveraging RNAi technology, imaging, and biomarkers.

Beyond her professional work, she is personally dedicated to the fight against Alzheimers and other dementias, actively encouraging support and donations for the cause. She is also passionate about supporting her professional community, proactively helping talented colleagues impacted by workforce reductions find new opportunities.

She received a grant from The Michael J. Fox Foundation for her work on a method to assess alpha-synuclein immunotherapy.

Personality Overview

Objective Thinker

Information Seeker

Precise

They like to take decisions independently and do not seek others' support often.  They don’t appreciate bells and whistles unless backed by data. They prefer to analyze logically and value objective facts over emotions.

Topics They Care About

CNS Drug Development
Her career is dedicated to leading clinical development programs for CNS disorders, including Alzheimer’s, Parkinson’s, and Huntington’s disease at companies like Alnylam and Vaxxinity.
RNAi Therapeutics
Her current role as Director at Alnylam Pharmaceuticals is focused on pioneering and developing innovative RNAi-based therapies for neurological conditions.
Ending Alzheimer's
Demonstrates a deep personal commitment by actively fundraising and raising awareness to support the fight against Alzheimer's and other dementias.

Media Appearances

Hui-Jing has no verified media appearances

Work History

7-2025
Director, Clinical Science at Alnylam Pharmaceuticals
2-2025 - 7-2025
Executive Director, Clinical Development at Axxium Life, Inc.
4-2024 - 2-2025
Executive Director at Vaxxinity
2-2023 - 4-2024
Senior Director at Vaxxinity
1-2018 - 2-2023
Medical Director at Vaxxinity

Education

2007 - 2011
Doctor of Philosophy (Ph.D.) from Stony Brook University
2001 - 2005
Bachelor’s Degree from Stony Brook University

More Information

Social Presence :

Prographics :

Exp : 25 Location : Cambridge, Massachusetts, United States Job Level : Mid-senior Designation : Director, Clinical Science at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Hui-Jing

During A Call Or A Meeting

DO's

  • Be formal and objective, they will appreciate it more
  • Leverage facts and figures wherever possible; use percentages, numbers etc.
  • Tell them what ROI they can expect

DONT's

  • Do not use very emotional or colorful language
  • Don’t try to give too many examples of other users, they like to make their own decisions
  • Don’t rush them till they have clearly gotten all the necessary information

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Hui-Jing is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Hui-Jing

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Hui-Jing move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Hui-Jing take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Hui-Jing

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.